Jörgen Jonsson
Universitetsadjunkt vid Institutionen för kirurgiska vetenskaper; Funktionell farmakologi och neurovetenskap
- Mobiltelefon:
- 070-860 88 54
- E-post:
- jorgen.jonsson@uu.se
- Besöksadress:
- BMC, Husargatan 3
751 24 Uppsala - Postadress:
- Kirurgiska vetenskaper, Box 593
751 24 Uppsala
Publikationer
Senaste publikationer
Ingår i Clinical Pharmacology and Therapeutics, s. 374-386, 2025
- DOI för Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
- Ladda ner fulltext (pdf) av Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Ingår i British Journal of Pharmacology, s. 3799-3818, 2024
- DOI för Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
- Ladda ner fulltext (pdf) av Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
Ingår i Frontiers in Psychiatry, 2024
- DOI för Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
- Ladda ner fulltext (pdf) av Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
Ingår i Pharmacological Research, 2024
- DOI för Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
- Ladda ner fulltext (pdf) av Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Ingår i International Journal of Molecular Sciences, 2022
- DOI för Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
- Ladda ner fulltext (pdf) av Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Alla publikationer
Artiklar i tidskrift
Ingår i Clinical Pharmacology and Therapeutics, s. 374-386, 2025
- DOI för Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
- Ladda ner fulltext (pdf) av Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations
Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Ingår i British Journal of Pharmacology, s. 3799-3818, 2024
- DOI för Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
- Ladda ner fulltext (pdf) av Off-target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
Ingår i Frontiers in Psychiatry, 2024
- DOI för Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
- Ladda ner fulltext (pdf) av Depression proteomic profiling in adolescents with transcriptome analyses in independent cohorts
Ingår i Pharmacological Research, 2024
- DOI för Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
- Ladda ner fulltext (pdf) av Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Ingår i British Journal of Clinical Pharmacology, s. 4577-4597, 2021
- DOI för Recent developments of HDAC inhibitors: Emerging indications and novel molecules
- Ladda ner fulltext (pdf) av Recent developments of HDAC inhibitors: Emerging indications and novel molecules
Ingår i Clinical Epigenetics, 2020
- DOI för meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes
- Ladda ner fulltext (pdf) av meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes
Ingår i Drug development research, s. 102-113, 2020
- DOI för A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
- Ladda ner fulltext (pdf) av A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants
Ingår i Epigenetics, s. 646-663, 2020
- DOI för Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression
- Ladda ner fulltext (pdf) av Longitudinal DNA methylation changes at MET may alter HGF/c-MET signalling in adolescents at risk for depression
Ingår i Scientific Reports, 2017
- DOI för SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo
- Ladda ner fulltext (pdf) av SLC10A4 regulates IgE-mediated mast cell degranulation in vitro and mast cell-mediated reactions in vivo
Conditional targeting of medium spiny neurons in the striatal matrix
Ingår i Frontiers in Behavioral Neuroscience, 2015
- DOI för Conditional targeting of medium spiny neurons in the striatal matrix
- Ladda ner fulltext (pdf) av Conditional targeting of medium spiny neurons in the striatal matrix
Artiklar, forskningsöversikt
Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Ingår i International Journal of Molecular Sciences, 2022
- DOI för Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
- Ladda ner fulltext (pdf) av Dissecting the Molecular Mechanisms Surrounding Post-COVID-19 Syndrome and Neurological Features
Ingår i Frontiers in Pharmacology, 2022
- DOI för Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
- Ladda ner fulltext (pdf) av Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules
Ingår i Frontiers in Pharmacology, 2022
- DOI för Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
- Ladda ner fulltext (pdf) av Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Role of the synergistic interactions of environmental pollutants in the development of cancer
Ingår i GeoHealth, 2022
- DOI för Role of the synergistic interactions of environmental pollutants in the development of cancer
- Ladda ner fulltext (pdf) av Role of the synergistic interactions of environmental pollutants in the development of cancer
Ingår i Expert Opinion on Drug Discovery, s. 1291-1307, 2020
- DOI för Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions
- Ladda ner fulltext (pdf) av Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions
Soluble ligands as drug targets
Ingår i Nature reviews. Drug discovery, s. 695-710, 2020